Name
#116 Guideline Concordant Cervical Cancer Screening Among Active-Duty Service Women in the U.S Military From 2017-2022
Speakers
Content Presented on Behalf of
Uniformed Services University
Services/Agencies represented
Uniformed Services University (USU)
Session Type
Posters
Room#/Location
Prince Georges Exhibit Hall A/B
Focus Areas/Topics
Clinical Care
Learning Outcomes
Following this session, the attendee will be able to:
1. Evaluate cervical cancer screening rates and compliance among active-duty servicewomen in the U.S. military, focusing on adherence to USPSTF guidelines.
2. Identify and analyzed disparities in cervical cancer screening compliance based on various factors.
3. Interpret the results to determine the likelihood of cervical cancer screening based on demographic factors, and propose targeted interventions to improve screening rates among underrepresented groups.
1. Evaluate cervical cancer screening rates and compliance among active-duty servicewomen in the U.S. military, focusing on adherence to USPSTF guidelines.
2. Identify and analyzed disparities in cervical cancer screening compliance based on various factors.
3. Interpret the results to determine the likelihood of cervical cancer screening based on demographic factors, and propose targeted interventions to improve screening rates among underrepresented groups.
Session Currently Live
Description
Background: Cervical cancer remains a significant health concern for women, with the U.S. Preventive Task Force (USPSTF) recommending routine screenings for women ages 21-65. The COVID-19 pandemic further disrupted cervical cancer screenings, exacerbating existing disparities and potentially increasing future cervical cancer risks. This study aims to evaluate cervical cancer screening rates among active-duty service women in the U.S. Military and assess the proportion meeting USPSTF guidelines during FY 2017-2022.
Methods: A retrospective cohort study of active-duty servicewomen ages 21-60 years with cervical cancer screening claims during FY 2017-2022. The cohort was identified with women screened for cervical cancer in FY 2017, who were then followed through FY 2022. Excluded from the study were reservists, National Guard and Coast Guard personnel. Screening compliance was determined based on USPSTF age-based guidelines. Analytic methods included descriptive statistics and logistic regression, to examine screening rates and compliance likelihood.
Results: Our analysis identified 212,081 active-duty servicewomen from the U.S. Army, Air Force, Navy, or Marines aged 21-60 during FY 2017. Among these, 62% were ages 21-29 and 38% were ages 30-60. Overall, 76.5% of eligible active-duty servicewomen received cervical cancer screenings. Women ages 30-60 were less likely to undergo screening (OR 0.73, 95% CI 0.71-0.74) compared to those aged 21-29. Similarly, senior officers showed lower screening rates compared to junior enlisted personnel (OR 0.78, 95% CI 0.74-0.82). Compliance with USPSTF guidelines varied by age group and military branch, with the Air Force and Navy showing lower compliance rates compared to the Army (OR 0.65, 95% CI 0.84-0.95; OR 0.86, 95% CI 0.82-0.91, respectively). Compliance rates were higher among servicewomen opting for 5-year screening intervals (98%) compared to 3-year intervals (82%).
Conclusion: Our study shows improved rates of cervical cancer screening among active-duty service women. Despite overall progress, disparities persist across military branches and racial groups, highlighting the need for targeted interventions to enhance screening rates among specific groups.